India’s FTAs pip generic drugs production Lot More For Less     * Generic drugs from India play a major role as antiretroviral drugs across the developing world     * A 2010 study says 80% of the medicines used by donor-funded programmes to treat people with HIV were sourced from India     * It’s cut down treatment costs drastically, from $10,000 to $80     * Stronger IP regimes may hamper production of generics *** The right of...

-The Times of India   Exactly a decade after farmers in Palnadu region sold their kidneys to clear their mounting debts, poverty-stricken women from the backward Palnadu region have fallen prey to clinical trials by a Hyderabad-based pharma company. The clinical tests on human beings, reportedly without the requisite permission of the state government, came to light on Thursday when some of the victims fell seriously ill in Piduguralla town. Many of...

-Express News Service The Tuberculosis Research Centre (TRC) in the city, on Wednesday, announced that it had isolated a molecule that fights both tuberculosis and some strains of HIV. Researchers isolated the molecule from a marine microorganism Streptomyces sp found in soil collected near coral reefs off the Rameshwaram coast. They found that the molecule was effective against Mycobacterium tuberculosis, the bacteria that causes most forms of TB. The molecule also acts...

-The Hindu   Communist Party of India (Marxist) Polit Bureau member Brinda Karat on Thursday demanded action against those responsible for allowing clinical trials of the human papillomavirus (HPV) vaccine in Andhra Pradesh and Gujarat without following the guidelines and ethics. Speaking at a seminar organised by the All-India Democratic Women's Association (AIDWA) here on “Cervical Cancer Vaccine — Consequences” the CPI(M) Rajya Sabha member said the poor in the country were...

Rs 3 lakh – that's the price a pharmaceutical company has paid to the family of a person who died in their clinical trial. Others weren't even this lucky. According to the Drug Controller General of India's (DCGI) records, 25 people died in clinical trials carried out by nine pharmaceutical companies in 2010. Families of five of these victims received "compensation for trial related death" — the amount ranging from Rs...